Value through Innovation27 July 2016

Clinical Study Results

  • METALYSE ® - Heart Arrest
    Clinical Study Number 1123.18
    Study Indication Heart Arrest
    Product METALYSE ®
    Generic Name Tenecteplase
    Lab Code
    Clinical Phase III
    Study Title

    A prospective, randomised, double-blind, placebo-controlled, international, multicentre, parallel-group comparison trial evaluating the efficacy and safety of tenecteplase during cardiopulmonary resuscitation as compared with standard treatment in patients suffering from out-of-hospital cardiac arrest of presumed cardiac origin. Thrombolysis in Cardiac Arrest (TROICA) Trial

    Study Document Trial statement 1123.18_CO english Trial synopsis 1123.18_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.